Carotenoids and apocarotenoids in cellular signaling related to cancer: A review

Molecular Nutrition and Food Research

Volumn 56, Issue 2, 2012, Pages 259-269

  Sharoni, Yoav ^a   Linnewiel Hermoni, Karin ^a   Khanin, Marina ^a   Salman, Hagar ^a   Veprik, Anna ^a   Danilenko, Michael ^a   Levy, Joseph ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Carotene; Antioxidants; EpRE ARE; Lycopene; Transcription

Indexed keywords

ANTINEOPLASTIC AGENT; CAROTENOID; ESTROGEN RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; RETINOIC ACID RECEPTOR; TRANSCRIPTION FACTOR;

ANIMAL; CELL PROLIFERATION; CHEMISTRY; DNA RESPONSIVE ELEMENT; DRUG EFFECT; FOOD; GENETICS; HUMAN; METABOLISM; NEOPLASM; PATHOLOGY; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; ANTINEOPLASTIC AGENTS; CAROTENOIDS; CELL PROLIFERATION; FOOD; HUMANS; NEOPLASMS; NF-KAPPA B; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; RECEPTORS, ESTROGEN; RECEPTORS, RETINOIC ACID; RESPONSE ELEMENTS; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

ANIMALIA;

EID: 84858323665     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201100311     Document Type: Review

References (68)

1. Mark, M., Ghyselinck, N. B., Chambon, P., Function of retinoid nuclear receptors: lessons from genetic and pharmacological dissections of the retinoic acid signaling pathway during mouse embryogenesis. Annu. Rev. Pharmacol. Toxicol. 2006, 46, 451-480.
2. von Lintig, J., Colors with functions: elucidating the biochemical and molecular basis of carotenoid metabolism. Annu. Rev. Nutr. 2010, 30, 35-56.
3. Caris-Veyrat, C., Schmid, A., Carail, M., Bohm, V., Cleavage products of lycopene produced by in vitro oxidations: characterization and mechanisms of formation. J. Agric. Food Chem. 2003, 51, 7318-7325.
4. Ukai, N., Lu, Y., Etho, H., Yagi, A. et al., Photosensitized oxygenation of lycopene. Biosci. Biotech. Biochem. 1994, 58, 1718-1719.
5. Aust, O., Ale-Agha, N., Zhang, L., Wollersen, H. et al., Lycopene oxidation product enhances gap junctional communication. Food Chem. Toxicol. 2003, 41, 1399-1407.
6. Kim, S. J., Nara, E., Kobayashi, H., Terao, J., Nagao, A., Formation of cleavage products by autoxidation of lycopene. Lipids 2001, 36, 191-199.
7. Nara, E., Hayashi, H., Kotake, M., Miyashita, K., Nagao, A., Acyclic carotenoids and their oxidation mixtures inhibit the growth of HL-60 human promyelocytic leukemia cells. Nutr. Cancer 2001, 39, 273-283.
8. Handelman, G. J., van Kuijk, F. J., Chatterjee, A., Krinsky, N. I., Characterization of products formed during the autoxidation of beta-carotene. Free Radic. Biol. Med. 1991, 10, 427-437.
9. Zhang, H., Kotake-Nara, E., Ono, H., Nagao, A., A novel cleavage product formed by autoxidation of lycopene induces apoptosis in HL-60 cells. Free Radic. Biol. Med. 2003, 35, 1653-1663.
10. Wyss, A., Wirtz, G., Woggon, W., Brugger, R. et al., Cloning and expression of beta, beta-carotene 15, 15′-dioxygenase. Biochem. Biophys. Res. Commun. 2000, 271, 334-336.
11. von Lintig, J., Wyss, A., Molecular analysis of vitamin A formation: cloning and characterization of beta-carotene 15, 15′-dioxygenases. Arch. Biochem. Biophys. 2001, 385, 47-52.
12. Lindqvist, A., Andersson, S., Biochemical properties of purified recombinant human beta-carotene 15, 15′-monooxygenase. J. Biol. Chem. 2002, 277, 23942-23948.
13. Lindqvist, A., Sharvill, J., Sharvill, D. E., Andersson, S., Loss-of-function mutation in carotenoid 15, 15′-monooxygenase identified in a patient with hypercarotenemia and hypovitaminosis A. J. Nutr. 2007, 137, 2346-2350.
14. Hessel, S., Eichinger, A., Isken, A., Amengual, J. et al., CMO1 deficiency abolishes vitamin A production from beta-carotene and alters lipid metabolism in mice. J. Biol. Chem. 2007, 282, 33553-33561.
15. Hu, K. Q., Liu, C., Ernst, H., Krinsky, N. I. et al., The biochemical characterization of ferret carotene-9′, 10′-monooxygenase catalyzing cleavage of carotenoids in vitro and in vivo. J. Biol. Chem. 2006, 281, 19327-19338.
16. Kiefer, C., Hessel, S., Lampert, J. M., Vogt, K. et al., Identification and characterization of a mammalian enzyme catalyzing the asymmetric oxidative cleavage of provitamin A. J. Biol. Chem. 2001, 276, 14110-14116.
17. Amengual, J., Lobo, G. P., Golczak, M., Li, H. N. et al., A mitochondrial enzyme degrades carotenoids and protects against oxidative stress. FASEB J. 2011, 25, 948-959.
18. Walfisch, Y., Walfisch, S., Agbaria, R., Levy, J., Sharoni, Y., Lycopene in serum, skin and adipose tissues after tomato-oleoresin supplementation in patients undergoing haemorrhoidectomy or peri-anal fistulotomy. Br. J. Nutr. 2003, 90, 759-766.
19. Ben-Aziz, A., Britton, G., Goodwin, T. W., Carotene epoxides of Lycopersicon esculentum. Phytochemistry 1973, 12, 2759-2764.
20. Kopec, R. E., Riedl, K. M., Harrison, E. H., Curley, R. W., Jr. et al., Identification and quantification of apo-lycopenals in fruits, vegetables, and human plasma. J. Agric. Food Chem. 2010, 58, 3290-3296.
21. Linnewiel, K., Ernst, H., Caris-Veyrat, C., Ben-Dor, A. et al., Structure activity relationship of carotenoid derivatives in activation of the electrophile/antioxidant response element transcription system. Free Radic. Biol. Med. 2009, 47, 659-667.
22. Gajic, M., Zaripheh, S., Sun, F., Erdman, J. W., Jr., Apo-8′-lycopenal and apo-12′-lycopenal are metabolic products of lycopene in rat liver. J. Nutr. 2006, 136, 1552-1557.
23. Zaripheh, S., Boileau, T. W., Lila, M. A., Erdman, J. W., Jr., [14C]-lycopene and [14C]-labeled polar products are differentially distributed in tissues of F344 rats prefed lycopene. J. Nutr. 2003, 133, 4189-4195.
24. Zaripheh, S., Erdman, J. W., Jr., The biodistribution of a single oral dose of [14C]-lycopene in rats prefed either a control or lycopene-enriched diet. J. Nutr. 2005, 135, 2212-2218.
25. Kotake-Nara, E., Kushiro, M., Zhang, H., Sugawara, T. et al., Carotenoids affect proliferation of human prostate cancer cells. J. Nutr. 2001, 131, 3303-3306.
26. Ben-Dor, A., Nahum, A., Danilenko, M., Giat, Y. et al., Effects of acyclo-retinoic acid and lycopene on activation of the retinoic acid receptor and proliferation of mammary cancer cells. Arch. Biochem. Biophys. 2001, 391, 295-302.
27. Ford, N. A., Elsen, A. C., Zuniga, K., Lindshield, B. L., Erdman, J. W., Jr., Lycopene and apo-12′-lycopenal reduce cell proliferation and alter cell cycle progression in human prostate cancer cells. Nutr. Cancer 2011, 63, 256-263.
28. Bertram, J. S., King, T., Fukishima, L., Khachik, F., in: Sen, C. K., Sies, H., Baeuerle, P. A. (Eds), Antioxidant and Redox Regulation of Genes, Academic Press, London 2000, pp. 409-424.
29. Bertram, J. S., Carotenoids and gene regulation. Nutr. Rev. 1999, 57, 182-191.
30. Vine, A. L., Bertram, J. S., Upregulation of connexin 43 by retinoids but not by non-provitamin A carotenoids requires RARs. Nutr. Cancer 2005, 52, 105-113.
31. de The, H., Vivanco-Ruiz, M. M., Tiollais, P., Stunnenberg, H., Dejean, A., Identification of a retinoic acid responsive element in the retinoic acid receptor beta gene. Nature 1990, 343, 177-180.
32. Freemantle, S. J., Spinella, M. J., Dmitrovsky, E., Retinoids in cancer therapy and chemoprevention: promise meets resistance. Oncogene 2003, 22, 7305-7315.
33. Lian, F., Smith, D. E., Ernst, H., Russell, R. M., Wang, X. D., Apo-10′-lycopenoic acid inhibits lung cancer cell growth in vitro, and suppresses lung tumorigenesis in the A/J mouse model in vivo. Carcinogenesis 2007, 28, 1567-1574.
34. Marsh, R. S., Yan, Y., Reed, V. M., Hruszkewycz, D. et al., beta-Apocarotenoids do not significantly activate retinoic acid receptors alpha or beta. Exp. Biol. Med. (Maywood) 2010, 235, 342-348.
35. Eroglu, A., Hruszkewycz, D. P., Curley, R. W., Jr., Harrison, E. H., The eccentric cleavage product of beta-carotene, beta-apo-13-carotenone, functions as an antagonist of RXRalpha. Arch. Biochem. Biophys. 2010, 504, 11-16.
36. Krey, G., Braissant, O., L'Horset, F., Kalkhoven, E. et al., Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay. Mol. Endocrinol. 1997, 11, 779-791.
37. Kliewer, S. A., Forman, B. M., Blumberg, B., Ong, E. S. et al., Differential expression and activation of a family of murine peroxisome proliferator-activated receptors. Proc. Natl. Acad. Sci. USA 1994, 91, 7355-7359.
38. Grimaldi, P. A., Peroxisome proliferator-activated receptors as sensors of fatty acids and derivatives. Cell Mol. Life Sci. 2007, 64, 2459-2464.
39. Barish, G. D., Narkar, V. A., Evans, R. M., PPAR delta: A dagger in the heart of the metabolic syndrome. J. Clin. Invest. 2006, 116, 590-597.
40. Ziouzenkova, O., Plutzky, J., Lipolytic PPAR activation: New insights into the intersection of triglycerides and inflammation? Curr. Opin. Clin. Nutr. Metab. Care 2004, 7, 369-375.
41. Krinsky, N., Russell, R. M., Regarding the conversion of beta-carotene to vitamin A. Nutr. Rev. 2001, 59, 309.
42. Ziouzenkova, O., Orashanu, G., Sukhova, G., Lau, E. et al., Asymmetric cleavage of β-carotene yields a transcriptional repressor of RXR and PPAR responses. Mol. Endocrinol. 2007, 21, 77-88.
43. Ziouzenkova, O., Orasanu, G., Sharlach, M., Akiyama, T. E. et al., Retinaldehyde represses adipogenesis and diet-induced obesity. Nat. Med. 2007, 13, 695-702.
44. Ziouzenkova, O., Plutzky, J., Retinoid metabolism and nuclear receptor responses: new insights into coordinated regulation of the PPAR-RXR complex. FEBS Lett. 2008, 582, 32-38.
45. Yang, C. M., Lu, I. H., Chen, H. Y., Hu, M. L., Lycopene inhibits the proliferation of androgen-dependent human prostate tumor cells through activation of PPARgamma-LXRalpha-ABCA1 pathway. J. Nutr. Biochem. 2011, in press, doi: 10.1016/j.jnutbio.2010.10.006.
46. Henderson, B. E., Ross, R., Bernstein, L., Estrogens as a cause of human cancer: the Richard and Hinda Rosenthal Foundation award lecture. Cancer Res. 1988, 48, 246-253.
47. Fisher, B., Costantino, J. P., Wickerham, D. L., Redmond, C. K. et al., Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J. Natl. Cancer. Inst. 1998, 90, 1371-1388.
48. Cummings, S. R., Eckert, S., Krueger, K. A., Grady, D. et al., The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple outcomes of raloxifene evaluation. J. Am. Med. Assoc. 1999, 281, 2189-2197.
49. Cui, Y., Shikany, J. M., Liu, S., Shagufta, Y., Rohan, T. E., Selected antioxidants and risk of hormone receptor-defined invasive breast cancers among postmenopausal women in the Women's Health Initiative Observational Study. Am. J. Clin. Nutr. 2008, 87, 1009-1018.
50. Hirsch, K., Atzmon, A., Danilenko, M., Levy, J., Sharoni, Y., Lycopene and other carotenoids inhibit estrogenic activity of 17β-estradiol and genistein in cancer cells. Breast Cancer Res. Treat. 2007, 104, 221-230.
51. Veprik, A., Khanin, M., Linnewiel Hermoni, K., Danilenko, M. et al., Polyphenols, isothiocyanates and carotenoid derivatives enhance estrogenic activity in bone cells but inhibit it in breast cancer cells. Am. J. Physiol. Endocrinol. Metab. 2011, in press, doi: 10.1152/apendo.00142.2011.
52. Dinkova-Kostova, A. T., Holtzclaw, W. D., Cole, R. N., Itoh, K. et al., Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants. Proc. Natl. Acad. Sci. USA 2002, 99, 11908-11913.
53. Kearns, A. E., Khosla, S., Kostenuik, P. J., Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulation of bone remodeling in health and disease. Endocr. Rev. 2008, 29, 155-192.
54. Shen, G., Jeong, W. S., Hu, R., Kong, A. N., Regulation of Nrf2, NF-kappaB, and AP-1 signaling pathways by chemopreventive agents. Antioxid. Redox Signal 2005, 7, 1648-1663.
55. Yu, S., Kong, A. N., Targeting carcinogen metabolism by dietary cancer preventive compounds. Curr. Cancer Drug Targets 2007, 7, 416-424.
56. Ben-Dor, A., Steiner, M., Gheber, L., Danilenko, M. et al., Carotenoids activate the antioxidant response element transcription system. Mol. Cancer Ther. 2005, 4, 177-186.
57. Khachik, F., Carvalho, L., Bernstein, P. S., Muir, G. J. et al., Chemistry, distribution, and metabolism of tomato carotenoids and their impact on human health. Exp. Biol. Med. (Maywood) 2002, 227, 845-851.
58. Giuliano, G., Al-Babili, S., von Lintig, J., Carotenoid oxygenases: cleave it or leave it. Trends Plant Sci. 2003, 8, 145-149.
59. Huang, C. S., Fan, Y. E., Lin, C. Y., Hu, M. L., Lycopene inhibits matrix metalloproteinase-9 expression and down-regulates the binding activity of nuclear factor-kappa B and stimulatory protein-1. J. Nutr. Biochem. 2007, 18, 449-456.
60. Bonvissuto, G., Minutoli, L., Morgia, G., Bitto, A. et al., Effect of Serenoa repens, lycopene, and selenium on proinflammatory phenotype activation: an in vitro and in vivo comparison study. Urology 2011, 77, 248. e249-e216.
61. Palozza, P., Colangelo, M., Simone, R., Catalano, A. et al., Lycopene induces cell growth inhibition by altering mevalonate pathway and Ras signaling in cancer cell lines. Carcinogenesis 2010, 31, 1813-1821.
62. Palozza, P., Serini, S., Torsello, A., Di Nicuolo, F. et al., Beta-carotene regulates NF-kappaB DNA-binding activity by a redox mechanism in human leukemia and colon adenocarcinoma cells. J. Nutr. 2003, 133, 381-388.
63. Lee, S. J., Bai, S. K., Lee, K. S., Namkoong, S. et al., Astaxanthin inhibits nitric oxide production and inflammatory gene expression by suppressing I(kappa)B kinase-dependent NF-kappaB activation. Mol. Cells 2003, 16, 97-105.
64. De Stefano, D., Maiuri, M. C., Simeon, V., Grassia, G. et al., Lycopene, quercetin and tyrosol prevent macrophage activation induced by gliadin and IFN-gamma. Eur. J. Pharmacol. 2007, 566, 192-199.
65. Guruvayoorappan, C., Kuttan, G., Beta-carotene inhibits tumor-specific angiogenesis by altering the cytokine profile and inhibits the nuclear translocation of transcription factors in B16F-10 melanoma cells. Integr. Cancer Ther. 2007, 6, 258-270.
66. Karas, M., Amir, H., Fishman, D., Danilenko, M. et al., Lycopene interferes with cell cycle progression and insulin-like growth factor I signaling in mammary cancer cells. Nutr. Cancer 2000, 36, 101-111.
67. Kalariya, N. M., Ramana, K. V., Srivastava, S. K., van Kuijk, F. J., Carotenoid derived aldehydes-induced oxidative stress causes apoptotic cell death in human retinal pigment epithelial cells. Exp. Eye Res. 2008, 86, 70-80.
68. Reynaud, E., Aydemir, G., Ruhl, R., Dangles, O., Caris-Veyrat, C., Organic synthesis of new putative lycopene metabolites and preliminary investigation of their cell-signaling effects. J. Agric. Food Chem. 2011, 59, 1457-1463.